SANGAMO THERAPEUTICS, INC vs 4D Molecular Therapeutics, Inc., risk disclosures compared

3topics both disclose

5only SANGAMO THERAPEUTICS, INC

1only 4D Molecular Therapeutics, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	SANGAMO THERAPEUTICS, INC	4D Molecular Therapeutics, Inc.
Ransomware	10	3
Internal Control	5	6
Restatement	6	5

Only SANGAMO THERAPEUTICS, INC

Topic	Filings
Business Continuity	13
Cross Border Data Transfer	5
Artificial Intelligence	1
Regulatory Investigation	1
Whistleblower Program	1

Only 4D Molecular Therapeutics, Inc.

Topic	Filings
Third Party Risk Management	3

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

SANGAMO THERAPEUTICS, INC · 4D Molecular Therapeutics, Inc. · All companies